5 new biologic device launches or releases in 2018

Here are five new biologic device launches or releases in 2018 so far:

Advertisement

Kleiner Device Labs initiated a full commercial launch of its spinal bone graft delivery tool.

Spine Wave launched the GraftMag Graft Delivery System.

Royal Biologics introduced Amnio-Maxx, an amniotic stem cell product.

Aziyo Biologics launched OsteGro, an allograft bone matrix designed to support new bone growth in procedures.

NuVasive launched the AttraX Scaffold in the U.S. for use in the posterolateral spine to promote fusion.

More articles on biologics:

3 things to know about the NanoFuse Bioactive Matrix

SpineMark enters strategic partnership with Regenexx to boost biologic options, patient volume: 4 key points

NanoFuse Biologics adds orthobiologics executive: 3 insights

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Biologics

Advertisement

Comments are closed.